Menu ×

HEALTHCARE & PHARMACEUTICAL

Bell’s Palsy Treatment Market Segmentation by Diagnosis {Magnetic Resonance Imaging (MRI), Computed Tomography (CT) Scan, Positron Emission Tomography (PET) Scan, Electromyography, and Others}; by Treatment {Medications (Corticosteroids, Antiviral Drugs, and Others), Physical Therapy, and Surgery}; and by End-User (Hospital, Specialty Clinics, and Others) – Global Demand Analysis & Opportunity Outlook 2030

  • Text Size:

Extensive insights into the Growth of Bell’s Palsy Treatment Market amidst COVID-19

Before we witness the stabilization of economic growth in Europe and North America, Asia Pacific is estimated to bounce back progressively with countries such as China, India, South Korea and Japan witnessing more opportunities to recover from the losses sustained during COVID-19.

Being the biggest market in Eastern Europe, Russia is estimated to take the lowest hit, offering a sigh of relief to the businesses operating in the country. Whereas, GCC is estimated to observe low investments due to the sliding prices of crude oil.

We evaluate the strategies and commitment of the Giant Players in the market towards creating products and services that customers value and rely on.

In an attempt to control and eliminate the surge of coronavirus cases and meet the demand for required medical devices along with providing efficient medical services, there is a drastic shift of investments from authoritative bodies towards the healthcare sector. Where the aftermath of this pandemic may take years to be measured, Research Nester estimates notable expansion of e-health, gaming, and media and entertainment industries till the whole situation is contained and the plan of action for the recovery process is determined. There is an estimated probability of the growth in businesses going back a year if the condition is controlled in the next 2-3 months.                                                         Request Insights

Read More

Global Bell’s Palsy Treatment Market Highlights over 2022 – 2030

The global Bell’s palsy treatment market is estimated to grow at a CAGR of ~9% over the forecast period, i.e., 2022 – 2030. The growth of the market can be attributed to the rising prevalence of viral infections, such as, chickenpox, rubella, herpes, and others, which are the primary cause of Bell’s palsy. According to the data by the U.S. National Library of Medicine, around 23 out of every 100,000 people are affected by Bell’s palsy per year across the globe. In this disease, inflammation occurs in the nerve that controls facial muscles, causing partial or even complete face paralysis. In most cases, control of either side of the face is lost, due to which one side droops down. Though, in most cases, the inflammation reduces in a few days or weeks, in some rare cases, it can be permanent or recurring. According to the report by the National Organization for Rare Disorders (NORD), approximately 80% of all cases are cured within three months. Targeting the viral infection is the most common treatment method adopted by doctors. The increasing cases of diabetes, AIDS, and other diseases which reduce or compromise the immunity of the patients, are estimated to boost the market growth, along with the unhealthy lifestyle of the population.

Bell’s Palsy Treatment Market

The market is segmented by treatment into medication, physical therapy, and surgery, out of which, the medication segment is anticipated to hold the largest revenue share in the global Bell’s palsy treatment market over the forecast period on the back of increasing prevalence of this disease, as most doctors opt drugs and medications for treating the neurological condition, and the viral infection. Surgery is required only in most critical cases. CLICK TO DOWNLOAD SAMPLE REPORT

Major Macro-Economic Indicators Impacting the Market Growth

Healthcare Expenditure

According to the statistics by the World Health Organization, the global per capita healthcare expenditure amounted to USD 1,064.741 in the year 2017. The worldwide healthcare expenditure per person grew from USD 864.313 in 2008 to USD 1,110.841 in 2018, where the U.S. is the top country that amounted to healthcare expenditure of USD 10, 623.85 per capita in 2018. As of 2018, the domestic general government healthcare spending in the U.S. was USD 5355.79, which grew from USD 3515.82 in 2008. These are some of the factors responsible for market growth over the past few years. Moreover, as per the projections by the Centers for Medicare & Medicaid Services (CMS), the estimated average annual percent change related to National Health Expenditures (NHE) in the U.S. was 5.2% in 2020 as compared to 2019 (4.5%). Furthermore, the National Health Expenditures are projected to reach USD 6,192.5 Billion in 2028, where the per capita expenditure is estimated to touch USD 17,611 in the same year. These are notable indicators that are anticipated to create lucrative business opportunities in upcoming years.

Global Bell’s Palsy Treatment Market Regional Synopsis

On the basis of geographical analysis, the global Bell’s palsy treatment market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. The market in Asia Pacific region is estimated to witness substantial growth over the forecast period on the back of emergent healthcare infrastructure and improved medical facilities available in developing nations, such as, India, Bangladesh, and Indonesia. Moreover, lack of sanitation and health awareness is a major issue in developing countries, which can be a cause for viral infection. This is estimated to boost the market growth.

The market in the North America region is anticipated to gain the largest market share throughout the forecast period on account of high healthcare expenditure, presence of major pharmaceutical companies, and increasing research activities for the development of new drugs. According to the statistics by the World Bank, in 2018, North America spent USD 10,050.516 for the healthcare of every individual. The total healthcare expenditure accounted for 16.415% of the total GDP of North America.  

Bell’s Palsy Treatment Market

The global Bell’s palsy treatment market is further classified on the basis of region as follows:

  • North America (U.S. & Canada) Market size, Y-O-Y growth & Opportunity Analysis
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth & Opportunity Analysis
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC, Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y growth & Opportunity Analysis
  • Asia-Pacific (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y growth & Opportunity Analysis
  • Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth & Opportunity Analysis

Market Segmentation

Our in-depth analysis of the global Bell’s palsy treatment market includes the following segments:

By Diagnosis

  • Magnetic Resonance Imaging (MRI)
  • Computed Tomography (CT) Scan
  • Positron Emission Tomography (PET) Scan
  • Electromyography
  • Others

By Treatment

  • Medication
  • Physical Therapy
  • Surgery

By End-User

  • Hospital
  • Specialty Clinics
  • Others

Growth Drivers

  • Increasing Incidences of Viral Infection
  • Poor Immunity and Unhealthy Lifestyle of People

Challenges

  • Lack of Health Awareness Amongst People
  • Circulation of Generic Drugs

Top Featured Companies Dominating the Market

  • Astellas Pharma Inc.
    • Company Overview
    • Business Strategy
    • Key Product Offerings
    • Financial Performance
    • Key Performance Indicators
    • Risk Analysis
    • Recent Development
    • Regional Presence
    • SWOT Analysis
  • tVNS Technologies GmbH
  • Novartis AG
  • Sanofi-aventis Groupe
  • Abbott Laboratories
  • Merck & Co., Inc.
  • Siemens Healthcare GmbH
  • Pfizer Inc.
  • Eli Lilly and Company
  • BioControl Medical

FREQUENTLY ASKED QUESTIONS


Related Reports


Disclaimer | Privacy Policy | Terms & Conditions

Copyright © 2021 Research Nester. All Rights Reserved